Phase 2 Heart Failure With Preserved Ejection Fraction (HFpEF) Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF)
Cytokinetics60 enrolled25 locationsNCT06793371
Recruiting
Phase 2
Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction
Coronary Artery DiseaseHeart Failure With Preserved Ejection Fraction (HFpEF)
King's College London350 enrolled1 locationNCT07560436
Recruiting
Phase 2
A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
ObesityHeart Failure With Preserved Ejection Fraction (HFpEF)Heart Failure With Mildly Reduced Ejection Fraction
Innovent Biologics (Suzhou) Co. Ltd.141 enrolled1 locationNCT06862908